Gilles Chatellier

Professor

Université Paris Cité

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Gilles Chatellier is a faculty member at Université Paris Cité in France. His research focuses on clinical data management, telemedicine interventions, and the treatment of various medical conditions, particularly in the context of cancer therapies and management strategies. His recent publications include studies on benign paroxysmal positional vertigo, prostatic artery embolization, and the impact of SARS-CoV-2 on cancer prognosis.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (5)

Guillaume Lamé

Lecturer / Assistant Professor

CentraleSupélec

FRANCE

View details

Tigran Poghosyan

Associate professor, MD, PhD

Université de Paris Faculté de Santé

FRANCE

View details

Claire Carette

Université Paris Cité

FRANCE

View details

Xavier Tannier

Sorbonne Université

FRANCE

View details

Thomas Guyet

Inria Centre de Recherche Grenoble Rhone-Alpes

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gilles Chatellier

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Improving benign paroxysmal positional vertigo management in the emergency department: A longitudinal study post–GRACE‐3

Collaborative and privacy-enhancing workflows on a clinical data warehouse: an example developing natural language processing pipelines to detect medical conditions

Decoding the complexity of benign prostatic hyperplasia therapies in the PARTEM trial—authors’ reply

MyGood Trip, a Telemedicine Intervention for Physical Activity Recovery After Bariatric Surgery: Randomized Controlled Trial

Is prostatic artery embolization a relevant treatment after a failed alpha-blocker monotherapy?—Authors’ reply

Influence of the SARS-CoV-2 outbreak on management and prognosis of new lung cancer cases, a retrospective multicentre real-life cohort study

Head computed tomography for elderly patients with acute altered mental status in the emergency setting: value for decision-making and predictors of abnormal findings

Transarterial Radioembolization Versus Atezolizumab–Bevacizumab in Unresectable Hepatocellular Carcinoma: A Matching-Adjusted Indirect Comparison of Time to Deterioration in Quality of Life

New cancer cases at the time of SARS-Cov2 pandemic and related public health policies: A persistent and concerning decrease long after the end of the national lockdown

Health-related quality of life in locally advanced hepatocellular carcinoma treated by either radioembolisation or sorafenib (SARAH trial)

Collaborators (5)

Guillaume Lamé

Tigran Poghosyan

Claire Carette

Xavier Tannier

Thomas Guyet

Make your next move.